TFF PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
TFF PHARMACEUTICALS, INC. reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of $31.80 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2023-03-31
- TFF PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2022 was $31.80M, a 2.58% increase from fiscal 2021.
- TFF PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2021 was $31.00M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|
| 2022-12-31 | $31.80M 10-K · filed 2023-03-31 |
| 2021-12-31 | $31.00M 10-K · filed 2023-03-31 |